Literature DB >> 712641

The rates of interaction of local anesthetics with sodium channels in nerve.

K R Courtney, J J Kendig, E N Cohen.   

Abstract

Voltage clamp experiments were carried out on Rana catesbiana nodes of Ranvier in order to test predictions regarding the relationship between local anesthetic lipid solubility and the rate of development of and recovery from frequency-dependent increments of sodium channel block. Contrary to expectations, the drugs of greater lipid solubility than lidocaine showed slower rates of development of frequency-dependent block and, in addition, induced longer rather than shorter memories for recent frequency-depent increments in channel block. Relaxation time constants for bupivacaine (50 micrometer), etidocaine (15 micrometer) and tetracaine (0.7 micrometer) measured 50, 8 and 8 sec, respectively, compared to shorter time constant of 2 sec for lidocaine (250 micrometer). Rate constants were calculated for binding to channels in both open and closed states. Open channels displayed a 130- to 6000-fold greater affinity for the local anesthetics than did closed channels, verifying an important feature of the "modulated receptor" hypothesis. In addition, binding to closed channels was enhanced by holding the membrane at more depolarizing potentials, which favored the development of inactive channel states. The exceptionally large binding constants of lidocaine for interactions with both closed and open channels cannot be attributed to its lipid solubility characteristics alone.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 712641

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

1.  A method for estimation of drug affinity constants to the open conformational state of calcium channels.

Authors:  E N Timin; S Hering
Journal:  Biophys J       Date:  1992-09       Impact factor: 4.033

2.  A quantitative description of QX222 blockade of sodium channels in squid axons.

Authors:  C F Starmer; J Z Yeh; J Tanguy
Journal:  Biophys J       Date:  1986-04       Impact factor: 4.033

Review 3.  Subtype-selective targeting of voltage-gated sodium channels.

Authors:  Steve England; Marcel J de Groot
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

4.  Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.

Authors:  D S Ragsdale; J C McPhee; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

5.  Kinetics of local anesthetic inhibition of neuronal sodium currents. pH and hydrophobicity dependence.

Authors:  D M Chernoff; G R Strichartz
Journal:  Biophys J       Date:  1990-07       Impact factor: 4.033

6.  Kinetic analysis of phasic inhibition of neuronal sodium currents by lidocaine and bupivacaine.

Authors:  D M Chernoff
Journal:  Biophys J       Date:  1990-07       Impact factor: 4.033

7.  Characterization of concentration- and use-dependent effects of quinidine from conduction delay and declining conduction velocity in canine Purkinje fibers.

Authors:  D L Packer; A O Grant; H C Strauss; C F Starmer
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

8.  Effects of various structurally related beta-adrenoceptor blocking agents on maximum upstroke velocity of action potential in guinea-pig papillary muscles.

Authors:  H Sada; T Ban
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

9.  The response of cat spinal motoneurones to the intracellular application of agents with local anaesthetic action.

Authors:  I Engberg; J A Flatman; J D Lambert
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

10.  The external pore loop interacts with S6 and S3-S4 linker in domain 4 to assume an essential role in gating control and anticonvulsant action in the Na(+) channel.

Authors:  Ya-Chin Yang; Jui-Yi Hsieh; Chung-Chin Kuo
Journal:  J Gen Physiol       Date:  2009-08       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.